Trials / Completed
CompletedNCT00111722
Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)
A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg Tablets for the Treatment of Menstrual Migraine
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 393 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0462, rizatriptan benzoate / Duration of Treatment -1day | |
| DRUG | Comparator: placebo / Duration of Treatment - 1 day |
Timeline
- Start date
- 2005-05-27
- Primary completion
- 2006-02-15
- Completion
- 2006-02-23
- First posted
- 2005-05-25
- Last updated
- 2024-08-14
Source: ClinicalTrials.gov record NCT00111722. Inclusion in this directory is not an endorsement.